Current Challenges for IDO2 as Target in Cancer Immunotherapy

Immune checkpoint inhibitors have revolutionized the clinical approach of untreatable tumors and brought a breath of fresh air in cancer immunotherapy. However, the therapeutic effects of these drugs only cover a minority of patients and alternative immunotherapeutic targets are required. Metabolism...

Descripción completa

Detalles Bibliográficos
Autores principales: Mondanelli, Giada, Mandarano, Martina, Belladonna, Maria Laura, Suvieri, Chiara, Pelliccia, Cristina, Bellezza, Guido, Sidoni, Angelo, Carvalho, Agostinho, Grohmann, Ursula, Volpi, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097162/
https://www.ncbi.nlm.nih.gov/pubmed/33968089
http://dx.doi.org/10.3389/fimmu.2021.679953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097162/
https://www.ncbi.nlm.nih.gov/pubmed/33968089
http://dx.doi.org/10.3389/fimmu.2021.679953

Ejemplares similares